Pharmafile Logo
Pharmafocus logo
Advanced Search

oncology

Showing 15 posts of 322 posts found.

Old anti-drinking drug shows potential as cancer treatment

December 7, 2017
Research and Development Cancer, biotech, drugs, oncology, pharma, pharmaceutical

Disulfiram has been known as an anti-drinking compound for nearly seven decades. Initially, the compound was used in the vulcanisation …

News
portraits-1474_approved_cut

Access to Innovation: Beyond a ‘pharma-only’ approach

October 19, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, ecco, oncology

Peter Naredi, of ECCO, explores how a multi-dimensional approach is necessary to ensure that patients receive access to the most …

Feature

EMA responds to criticism of its cancer drug approvals

October 17, 2017
Manufacturing and Production, Medical Communications Cancer, EMA, biotech, drugs, oncology, pharma, pharmaceutical

The EMA received a broadside just less than two week ago from a group of researchers that had studied data …

News
ema_interior

57% of cancer drugs uses approved by EMA show no benefit

October 5, 2017
Sales and Marketing EMA, biotech, drugs, oncology, pharma, pharmaceutical

A new study conducted by King’s College London and LSE has found that of 48 treatments approved between 2009 and …

News
pharmafocus_september_2017_cover

The September 2017 issue of Pharmafocus is now live!

August 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Cancer Research UK, MSD, Pharmafocus, President trump, Takeda, Trump, charlottesville, life sciences, oncology, pharmaceuticals, phatma

The September edition of Pharmafocus is now available – click here to read online.

News

Takeda reveals collaboration aimed at bolstering oncology pipeline

August 8, 2017
Manufacturing and Production, Sales and Marketing Molecular Templates, Takeda, biotech, drugs, oncology, pharma, pharmaceutical

It is widely known that Takeda is keen to build its portfolio in oncology and it has made another move …

News
shutterstock_212035546

Investigational antibody boosts chemotherapy’s cancer-killing potential

June 29, 2017
Research and Development CFH, Cancer, oncology, rituximab

A proof-of-concept study conducted at the Duke Cancer Institute (DCI) in North Carolina has shown that an investigational antibody has …

News
shutterstock_187433765

New targeted therapy promises strong response rate across 17 cancer types

June 5, 2017
Research and Development, Sales and Marketing ASCO, Cancer, Loxo Oncology, oncology

Loxo Oncology’s lead therapy larotrectinib made a big impact at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, …

News
cancer_cells

ICR track cancer to ‘carbon date’ progression

May 11, 2017
Research and Development Cancer, ICR, bowel cancer, oncology

The Institute of Cancer Research (ICR) has collaborated with sites across Scotland, Italy and the US to study the disease …

News
surgery

Quarter of cancer patients visit GP three times with no diagnosis

April 25, 2017
Manufacturing and Production, Research and Development Cancer, GP, NHS, oncology

A recent study, published in the British Journal of General Practice, has found that 23% of those suffering from cancer …

News
shutterstock_141299494

Immunotherapy: The three major treatments that are changing cancer prognoses

March 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Cancer, MSD, Roche, immunotherapy, keytruda, oncology, opdivo, tecentriq

The promise of Immunotherapy as a game-changer for cancer treatment has been evident since its advent in the space. However, …

Feature
r3ws8b7e-web

Takeda discusses the importance of patient-focused market access

February 3, 2017
Medical Communications, Sales and Marketing Takeda, oncology

With World Cancer Day on 4 February, Takeda Oncology’s Liviu Niculescu and Stephen J. Noga talk to Pharmafile.com on the …

News

Two-decade-long prostate cancer study finds antiandrogen improves survival

February 2, 2017
Research and Development antiandrogen, oncology, prostate cancer

Research conducted over the course of two decades has found a positive correlation between overall survival in prostate cancer patients …

News
c_agsandrew_-_fotolia

Philips and Illumina partner up for integrated genomics oncology solution

January 11, 2017
Research and Development Illumina, Philips, oncology

Technology firm Philips and biotech Illumina have announced they are to partner up in collaboration which plans to marry the …

News
alessandro-riva

Gilead makes move in oncology by snaffling Riva from Novartis

January 4, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, Novartis, oncology

Gilead Sciences have made an ambitious move to boost its oncology business by appointing current head of global oncology development …

Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025